Jeffrey Statland

7.6k total citations
128 papers, 2.7k citations indexed

About

Jeffrey Statland is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jeffrey Statland has authored 128 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 50 papers in Neurology and 47 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jeffrey Statland's work include Muscle Physiology and Disorders (47 papers), Genetic Neurodegenerative Diseases (36 papers) and Neurogenetic and Muscular Disorders Research (33 papers). Jeffrey Statland is often cited by papers focused on Muscle Physiology and Disorders (47 papers), Genetic Neurodegenerative Diseases (36 papers) and Neurogenetic and Muscular Disorders Research (33 papers). Jeffrey Statland collaborates with scholars based in United States, Netherlands and United Kingdom. Jeffrey Statland's co-authors include Rabi Tawil, Richard J. Barohn, Chris J. McBain, J. Josh Lawrence, Mazen M. Dimachkie, Silvère M. van der Maarel, Stephen J. Tapscott, Zachary M. Grinspan, Mike A. Singer and Gil I. Wolfe and has published in prestigious journals such as JAMA, Journal of Neuroscience and Brain.

In The Last Decade

Jeffrey Statland

121 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey Statland United States	32	1.6k	1.0k	796	625	625	128	2.7k
Valeria Sansone Italy	36	2.3k 1.4×	1.7k 1.7×	1.4k 1.7×	762 1.2×	887 1.4×	175	3.9k
Lundy Day Canada	10	730 0.5×	522 0.5×	491 0.6×	214 0.3×	153 0.2×	16	2.1k
H. J. ter Laak Netherlands	25	1.3k 0.8×	485 0.5×	367 0.5×	179 0.3×	224 0.4×	76	2.7k
D J Dick United Kingdom	25	865 0.5×	590 0.6×	699 0.9×	103 0.2×	336 0.5×	63	2.4k
Yuishin Izumi Japan	31	805 0.5×	871 0.9×	1.7k 2.2×	476 0.8×	69 0.1×	218	3.2k
Eiji Nakagawa Japan	25	900 0.6×	547 0.5×	219 0.3×	200 0.3×	99 0.2×	177	2.6k
Wolf‐Rüdiger Schäbitz Germany	30	563 0.4×	646 0.6×	701 0.9×	320 0.5×	79 0.1×	56	3.1k
Ruxiang Xu China	32	970 0.6×	706 0.7×	319 0.4×	782 1.3×	39 0.1×	125	2.8k
Johanna Palmio Finland	27	851 0.5×	638 0.6×	465 0.6×	208 0.3×	290 0.5×	76	2.0k
Erik Henricson United States	23	1.8k 1.1×	256 0.3×	123 0.2×	461 0.7×	380 0.6×	70	2.4k

Countries citing papers authored by Jeffrey Statland

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Statland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Statland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Statland more than expected).

Fields of papers citing papers by Jeffrey Statland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Statland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Statland. The network helps show where Jeffrey Statland may publish in the future.

Co-authorship network of co-authors of Jeffrey Statland

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Statland. A scholar is included among the top collaborators of Jeffrey Statland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Statland. Jeffrey Statland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Hunt, Suzanne, et al.. (2024). Outcomes after intervention for enteral nutrition in patients with amyotrophic lateral sclerosis in multidisciplinary clinics. Muscle & Nerve. 70(1). 94–100. 2 indexed citations

2.

Benatar, Michael, Eric A. Macklin, Andrea Malaspina, et al.. (2024). Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis. EBioMedicine. 108. 105323–105323. 14 indexed citations

3.

Wong, Chao-Jen, Seth D. Friedman, Lauren Snider, et al.. (2024). Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression. Human Molecular Genetics. 33(8). 698–708. 10 indexed citations

4.

Witzel, Simon, Jeffrey Statland, Petra Steinacker, et al.. (2023). Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis—insights from a completed randomized controlled trial with rasagiline. European Journal of Neurology. 31(3). e16154–e16154. 5 indexed citations

5.

Pasnoor, Mamatha, Vera Bril, Todd Levine, et al.. (2023). Phase 2 trial in acetylcholine receptor antibody‐positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study. European Journal of Neurology. 30(5). 1417–1424. 2 indexed citations

6.

Mul, Karlien, Judit Balog, Jessica C. de Greef, et al.. (2023). Facioscapulohumeral muscular dystrophy: the road to targeted therapies. Nature Reviews Neurology. 19(2). 91–108. 32 indexed citations

7.

Halseth, Amy E., T. Brandt, Hana Cho, et al.. (2023). P51 Phase 1/2 study to evaluate AOC 1020 for adult patients with facioscapulohumeral muscular dystrophy: FORTITUDE trial design. Neuromuscular Disorders. 33. S71–S71. 2 indexed citations

8.

Stunnenberg, Bas C., Robert C. Griggs, Jeffrey Statland, et al.. (2021). N-of-1 Trials in Neurology. Neurology. 98(2). e174–e185. 8 indexed citations

9.

Mul, Karlien, Corinne G.C. Horlings, Rabi Tawil, et al.. (2021). The facioscapulohumeral muscular dystrophy Rasch‐built overall disability scale (FSHD‐RODS). European Journal of Neurology. 28(7). 2339–2348. 10 indexed citations

10.

Attarian, Shahram, Peter Young, Thomas H. Brannagan, et al.. (2021). A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A. Orphanet Journal of Rare Diseases. 16(1). 433–433. 31 indexed citations

11.

McVey, April, Richard J. Barohn, Jeffrey Statland, et al.. (2020). Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets. Journal of Visualized Experiments. 1 indexed citations

12.

McVey, April, Richard J. Barohn, Jeffrey Statland, et al.. (2020). Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets. Journal of Visualized Experiments. 4 indexed citations

13.

Stunnenberg, Bas C., Samantha LoRusso, W. David Arnold, et al.. (2020). Guidelines on clinical presentation and management of nondystrophic myotonias. Muscle & Nerve. 62(4). 430–444. 46 indexed citations

14.

Turner, Martin R., Richard J. Barohn, Philippe Corcia, et al.. (2020). Primary lateral sclerosis: consensus diagnostic criteria. Journal of Neurology Neurosurgery & Psychiatry. 91(4). 373–377. 125 indexed citations

15.

Pasnoor, Mamatha, Andrew Heim, Laura Herbelin, et al.. (2020). Methotrexate Polyglutamation in a Myasthenia Gravis Clinical Trial. Kansas Journal of Medicine. 13(Suppl 2). 10–13. 3 indexed citations

16.

Pasnoor, Mamatha, Suzanne Hunt, Omar Jawdat, et al.. (2019). Retrospective longitudinal assessment of MG-ADL score with treatment of myasthenia gravis (P5.4-039). Neurology. 92(15_supplement). 1 indexed citations

17.

Goselink, Rianne J.M., Karlien Mul, Richard J.L.F. Lemmers, et al.. (2018). Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy. Neurology. 92(4). e378–e385. 32 indexed citations

18.

Statland, Jeffrey, Anthony A. Amato, Elena Bravver, et al.. (2018). Preliminary Results from a Phase 2 Study to Evaluate ACE-083, a Local Muscle Therapeutic, in Patients with Facioscapulohumeral Muscular Dystrophy (S38.001). Neurology. 90(15_supplement). 4 indexed citations

19.

Trivedi, Jaya, Brian N. Bundy, Jeffrey Statland, et al.. (2013). Non-dystrophic myotonia: prospective study of objective and patient reported outcomes. Brain. 136(7). 2189–2200. 76 indexed citations

20.

Lawrence, J. Josh, Fernanda Saraga, Jeffrey Statland, et al.. (2006). Somatodendritic Kv7/KCNQ/M Channels Control Interspike Interval in Hippocampal Interneurons. Journal of Neuroscience. 26(47). 12325–12338. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact